301230 泓博医药
2024/09 - 九个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)1.4103.3739.19424.06021.022
总资产报酬率 ROA (%)1.0712.6987.22716.20615.254
投入资产回报率 ROIC (%)1.1762.9257.84718.61917.656

边际利润分析
销售毛利率 (%)23.75630.87536.87438.68842.566
营业利润率 (%)1.6447.64615.21119.33619.538
息税前利润/营业总收入 (%)2.2447.38813.68720.26723.127
净利润/营业总收入 (%)3.8957.68214.02816.41617.206

收益指标分析
经营活动净收益/利润总额(%)-80.581107.78495.280100.76594.235
价值变动净收益/利润总额(%)116.05316.8900.6912.5513.017
营业外收支净额/利润总额(%)0.493-1.8540.105-0.501-0.138

偿债能力分析
流动比率 (X)4.1183.8249.2842.1542.782
速动比率 (X)3.6043.5038.7781.7912.052
资产负债率 (%)23.09124.85414.47637.53424.847
带息债务/全部投入资本 (%)3.4223.3692.50510.77613.777
股东权益/带息债务 (%)2,441.3182,473.3903,608.381672.302617.490
股东权益/负债合计 (%)333.069302.350590.777166.427302.468
利息保障倍数 (X)3.789-61.885-8.88519.7156.397

营运能力分析
应收账款周转天数 (天)67.35261.59364.13852.30862.091
存货周转天数 (天)62.84059.82258.26570.563107.857